Gastroenterology clinical trials recruiting in New York

34 recruiting gastroenterology trials match in New York. Showing 20.

• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting

  Phase 3 · Boehringer Ingelheim · Brooklyn, New York

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Brooklyn, New York

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Carmel, New York

• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesRecruiting

  Phase 2 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · New York, New York

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Sanofi · Maspeth, New York

• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 2 · Eli Lilly and Company · Brooklyn, New York

• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)Recruiting

  Phase 4 · Takeda · New York, New York

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Janssen Research & Development, LLC · Carmel, New York

• A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community SettingRecruiting

  Phase 4 · Takeda · Carmel, New York

• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseRecruiting

  Phase 3 · Takeda · Colorado Springs, Colorado

• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Sanofi · Maspeth, New York

• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's DiseaseRecruiting

  Phase 3 · Takeda · Orange, California

• Behavioral Therapy for Crohn's DiseaseRecruiting

  N/A · Icahn School of Medicine at Mount Sinai · New York, New York

• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · New Hyde Park, New York

• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Oklahoma City, Oklahoma

• A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)Recruiting

  Phase 2 · Eli Lilly and Company · New York, New York

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Recruiting

  Phase 2 · Eli Lilly and Company · Utica, New York

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisRecruiting

  Phase 3 · Boehringer Ingelheim · Brooklyn, New York

• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's DiseaseRecruiting

  Phase 3 · Eli Lilly and Company · New York, New York

• Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisRecruiting

  Phase 2 · AbbVie · New York, New York

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.